Penbrook Management’s Viemed Healthcare VMD Stock Holding History

Penbrook Management’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.51M	Buy	272,398 +850	+0.3%	+$7.07K	1.9%	13
2025 Q4	$2.02M	Sell	271,548 -780	-0.3%	-$5.34K	1.39%	15
2025 Q3	$1.85M	Sell	272,328 -114,269	-30%	-$774K	1.29%	15
2025 Q2	$2.75M	Buy	386,597 +180,020	+87%	+$1.22M	1.04%	21
2025 Q1	$1.5M	Sell	206,577 -7,280	-3%	-$57.2K	1.14%	20
2024 Q4	$1.72M	Hold	213,857	–	–	1.17%	17
2024 Q3	$1.57M	Sell	213,857 -17,750	-8%	-$127K	1.02%	20
2024 Q2	$1.52M	Buy	231,607 +162,670	+236%	+$1.23M	0.93%	21
2024 Q1	$650K	Sell	68,937 -850	-1%	-$7.29K	0.4%	54
2023 Q4	$548K	Sell	69,787 -450	-0.6%	-$3.27K	0.37%	62
2023 Q3	$473K	Buy	70,237 +19,387	+38%	+$159K	0.35%	66
2023 Q2	$497K	Hold	50,850	–	–	0.36%	64
2023 Q1	$491K	Buy	+50,850	New	+$443K	0.38%	63

Other funds holding VMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Penbrook Management's VMD Position: Q1 2026 in Review

Penbrook Management increased its Viemed Healthcare (VMD) stake by 0.31% in Q1 2026, buying an estimated $7.07K and bringing the position to 272,398 shares worth $2.51M. The position accounts for 1.9% of the portfolio, ranked #13.

Penbrook Management first reported a position in VMD in Q1 2023 and has held it in 13 quarters since. The position peaked at $2.75M in Q2 2025. 149 funds tracked by Wall St. Rank hold VMD as of Q1 2026.

Penbrook Management held 272,398 shares of Viemed Healthcare worth $2.51M as of Q1 2026.
Penbrook Management bought 850 Viemed Healthcare shares in Q1 2026, an estimated $7.07K.
Viemed Healthcare made up 1.9% of Penbrook Management's portfolio in Q1 2026, its #13 holding.
Penbrook Management first reported a position in Viemed Healthcare in Q1 2023 and has held it in 13 quarters since.
Penbrook Management's Viemed Healthcare position peaked at $2.75M in Q2 2025.
149 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2026.

Based on Penbrook Management's 13F filing for Q1 2026, filed 21 Apr 2026.